Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
News|Articles|June 30, 2026
- Dermatology Times, June 2026 (Vol. 47. No. 06)
- Volume 47
- Issue 06
Dermatology Times June 2026 Print Recap
Author(s)Marie Bosslett, Assistant Editor
Learn more about the in-depth topics covered in the June 2026 print issue of Dermatology Times.
Advertisement
Advertisement
The June issue of Dermatology Times includes a collection of thought-provoking articles and topics as we examine emerging evidence for ruxolitinib cream in hidradenitis suppurativa, explore the exciting update in US sunscreen formulations, review the Sun Bus’ community impact, and more.
Related to this article
Dermatology Times is looking back on the top stories in dermatology from the month of October.
Face taping promises smoother skin and fewer wrinkles without injectables, but evidence suggests any visible benefits are largely temporary.
A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.
At a Dermatology Times Case-Based Roundtable, Vishal A. Patel, MD, led a discussion on treatment selection, tolerability, and individualized care for patients with advanced basal cell carcinoma.
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
October brought FDA approvals in urticaria and HSV, new regulatory filings, and phase 3 advances in HS, psoriasis, and rare diseases.
Gaurav Singh, MD, explores how gene expression profiling may improve melanoma risk stratification, surveillance, and individualized care.
Advertisement
Advertisement